tiprankstipranks
Trending News
More News >
BriaCell Therapeutics Corp (BCTX)
NASDAQ:BCTX
US Market

BriaCell Therapeutics (BCTX) Financial Statements

Compare
266 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently C$20.30M. The company's EPS TTM is $-2.37458298; its P/E ratio is ―; BriaCell Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -20.49K$ -19.39K$ -19.44K$ -18.74K
Operating Income-$ -23.27M$ -15.29M$ -6.97M$ -3.94M
EBITDA-$ -22.37M$ -34.05M$ -6.95M$ -3.96M
Net Income-$ -20.30M$ -11.58M$ -2.90M$ 1.39M
Balance Sheet
Cash & Short-Term Investments$ 862.09K$ 21.25M$ 41.04M$ 57.27M$ 19.46K
Total Assets$ 5.87M$ 27.16M$ 42.58M$ 58.04M$ 478.31K
Total Debt$ 0.00$ 0.00$ 0.00$ 25.99K$ 228.75K
Net Debt$ -862.09K$ -21.25M$ -41.04M$ -57.24M$ 209.29K
Total Liabilities$ 8.56M$ 30.94M$ 32.25M$ 782.24K$ 3.77M
Stockholders' Equity$ -2.38M$ -3.78M$ 10.33M$ 57.26M$ 0.00
Cash Flow
Free Cash Flow$ -24.58M$ -23.74M$ -12.48M$ -7.75M-
Operating Cash Flow$ -24.13M$ -23.74M$ -12.48M$ -7.75M-
Investing Cash Flow$ -681.80K$ 0.00$ 0.00$ 0.00-
Financing Cash Flow$ 4.42M$ 3.95M$ -3.74M$ 65.00M$ 1.08M
Currency in USD

BriaCell Therapeutics Earnings and Revenue History

BriaCell Therapeutics Debt to Assets

BriaCell Therapeutics Cash Flow

BriaCell Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis